Huang C, Dong L, Zhao B, Lu Y, Huang S, Yuan Z
At approximately $120-150 per month, it is significantly less expensive than tirzepatide while offering comparable efficacy at higher doses
Female Fertility
Altimmunes GLP-1 agonist in the clinic Some biotechs think that by broadening the therapeutic scope of GLP-1 agonists, cardiovascular diseases can be addressed
This includes reducing the risk of heart attack, stroke, and cardiovascular death in people with type 2 diabetes
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial